Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T20:12:06.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a revision notice: Revision: v3.4.3, and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:12.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision from v3.4.1 to v3.4.2 appears to be a minor site version update with no changes to study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:33:37.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed on the page, replacing Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:30.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Minor version update: Revision v3.3.4 was added and Revision v3.3.3 was removed. It does not affect the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-01-15T05:12:47.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page’s Locations section was updated with new investigational sites across multiple countries and with some existing locations removed.
    Difference
    1%
    Check dated 2025-12-24T23:19:06.000Z thumbnail image

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.